Pfizer Medicaid pricing deal could save states $280M: Study
The drug-pricing agreement Pfizer struck with the Trump administration in September could generate up to $280 million in annual savings for state Medicaid programs, according to an analysis published April 27 in the Journal of Managed Care & Specialty Pharmacy. The agreement stems from a broader administration effort to tie U.S. drug prices to those […] The post Pfizer Medicaid pricing deal could save states $280M: Study appeared first on Becker's Hospital Review | Healthcare News...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.